• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Hip lawsuit update: Judge orders J&J and litigants to work together

Hip lawsuit update: Judge orders J&J and litigants to work together

September 4, 2012 By MassDevice staff

hip implant X-ray illustration

Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics must work together with plaintiffs who are suing the company over allegedly faulty hip implants, ordered U.S. District Judge Ed Kinkeade.

Judge Kinkeade, who is presiding over a multidistrict lawsuit combining more than 1,100 hip replacement cases against DePuy’s Pinnacle metal-on-metal hip implants, instructed plaintiffs and defendants to come to terms on a notice that will be sent to hospitals and physicians participating in the FDA-mandated Pinnacle explant studies.

The parties already once failed to come to an agreement on the wording of the letter, but Judge Kinkeade insisted they try again, according to a Rottenstein Law Group press release.

DePuy’s Pinnacle implants have not been the subject of a recall, but became the focus of heightened scrutiny amid the high-profile recall of the company’s metal-on-metal ASR implants, a move which spurred class action and multi-district lawsuits, public outcry and FDA scrutiny.

The Pinnacle device, which pre-dates DePuy’s ASR implant by a few years, is like its older cousin in that it’s been found to shed minute particles of metal as the hip’s ball joint wears on the metal cup. The lawsuits allege that increases the risk of problems and make the implants prone to early failure.

In May 2011 the FDA asked a clutch of device makers, including Biomet Inc., Stryker (NYSE:SYK) and Zimmer (NYSE:ZMH), to run post-market studies of their metal hip replacements in order to look for metal ions in patients’ blood.

It took Johnson & Johnson more than a year to submit its research protocol to the FDA and gain agency approval to proceed, but some researchers are skeptical that the studies will yield much in the way of worthwhile results, Drug Watch reported.

Researchers warned that the metal-on-metal hip studies aren’t well-organized, in that each manufacturer will come up with their own protocol, making the data difficult to pool and draw larger conclusions from. In addition, the studies must span only 3 years, about ⅓ of the devices’ expected lifespan.

Filed Under: Legal News, Metal-on-Metal, News Well, Recalls Tagged With: depuysynthes, Hips, Johnson and Johnson

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy